Substituted isoxazol-3 ylcarbamoylmethyl-1-azonia bicyclo[2.2.2]octane compound

PK140685AUndetermined Publication Date: 2010-04-26NOVARTIS AG
0 Cites 0 Cited by

Patent Information

Application Number
PK200400315
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2010-04-26
Patent Text Reader

Abstract

compound of formula I wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, is used for treating conditions that are medicated by the muscarinic M3 receptor. Pharmaceutical composition that contain the compound is also described
Need to check novelty before this filing date? Find Prior Art